Liu Q
Clin Exp Med. 2025; 25(1):77.
PMID: 40063304
PMC: 11893680.
DOI: 10.1007/s10238-025-01618-x.
Shirani N, Abdi N, Chehelgerdi M, Yaghoobi H, Chehelgerdi M
Front Cell Dev Biol. 2025; 13:1485422.
PMID: 39925739
PMC: 11802832.
DOI: 10.3389/fcell.2025.1485422.
Geng S, Lv X, Xu T
EMBO Rep. 2025; 26(5):1196-1211.
PMID: 39885293
PMC: 11893794.
DOI: 10.1038/s44319-025-00379-8.
Thakur A, Kumar M
Methods Mol Biol. 2024; 2883:299-323.
PMID: 39702714
DOI: 10.1007/978-1-0716-4290-0_13.
Zhu Z, Xuan W, Wang C, Li C
Front Oncol. 2024; 14:1481777.
PMID: 39655078
PMC: 11625809.
DOI: 10.3389/fonc.2024.1481777.
A review of the complex interplay between chemoresistance and lncRNAs in lung cancer.
Alnefaie G
J Transl Med. 2024; 22(1):1109.
PMID: 39639388
PMC: 11619437.
DOI: 10.1186/s12967-024-05877-2.
Advantages of the zebrafish tumor xenograft model: the evaluation of efficacy in cancer therapy and the application to the study of lncRNAs.
Hu C, Sun L, Chen J, Lyu Z, Yuan C, Jiang X
Front Immunol. 2024; 15:1483192.
PMID: 39403375
PMC: 11471560.
DOI: 10.3389/fimmu.2024.1483192.
Neuroendocrine transdifferentiation in human cancer: molecular mechanisms and therapeutic targets.
Jiang J, Han D, Wang J, Wen W, Zhang R, Qin W
MedComm (2020). 2024; 5(10):e761.
PMID: 39372390
PMC: 11450264.
DOI: 10.1002/mco2.761.
p53 Regulates Nuclear Architecture to Reduce Carcinogen Sensitivity and Mutagenic Potential.
King D, McCoy D, Perdyan A, Mieczkowski J, Douki T, Dionne J
bioRxiv. 2024; .
PMID: 39345432
PMC: 11429700.
DOI: 10.1101/2024.09.14.613067.
Exploring the Spectrum of Long Non-Coding RNA CARMN in Physiological and Pathological Contexts.
Li H, Sun C, Luo B, Zhan C, Li W, Deng L
Biomolecules. 2024; 14(8).
PMID: 39199342
PMC: 11353180.
DOI: 10.3390/biom14080954.
Non-coding RNAs in BRAF-mutant melanoma: targets, indicators, and therapeutic potential.
Afsar S, Syed R, Khojali W, Masood N, Osman M, Jyothi J
Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(1):297-317.
PMID: 39167168
DOI: 10.1007/s00210-024-03366-3.
Progress and trends in myocardial infarction-related long non-coding RNAs: a bibliometric analysis.
Meng Q, Tan H, Wang C, Sun Z
Front Mol Biosci. 2024; 11:1382772.
PMID: 39135912
PMC: 11317247.
DOI: 10.3389/fmolb.2024.1382772.
Exploring the Utility of Long Non-Coding RNAs for Assessing the Health Consequences of Vaping.
Besaratinia A, Blumenfeld H, Tommasi S
Int J Mol Sci. 2024; 25(15).
PMID: 39126120
PMC: 11313266.
DOI: 10.3390/ijms25158554.
The temporal dynamics of lncRNA Firre-mediated epigenetic and transcriptional regulation.
Much C, Lasda E, Pereira I, Vallery T, Ramirez D, Lewandowski J
Nat Commun. 2024; 15(1):6821.
PMID: 39122712
PMC: 11316132.
DOI: 10.1038/s41467-024-50402-0.
CBIL-VHPLI: a model for predicting viral-host protein-lncRNA interactions based on machine learning and transfer learning.
Zhang M, Zhang L, Liu T, Feng H, He Z, Li F
Sci Rep. 2024; 14(1):17549.
PMID: 39080344
PMC: 11289117.
DOI: 10.1038/s41598-024-68750-8.
GAS6-AS1 drives bladder cancer progression by increasing MMP7 expression in a ceRNA- and RBP-dependent manner.
Zhou X, Xiao L, Meng F, Zuo F, Wu W, Li G
Transl Oncol. 2024; 48:102065.
PMID: 39053343
PMC: 11326496.
DOI: 10.1016/j.tranon.2024.102065.
Functional roles of conserved lncRNAs and circRNAs in eukaryotes.
Li J, Wang X
Noncoding RNA Res. 2024; 9(4):1271-1279.
PMID: 39036601
PMC: 11260338.
DOI: 10.1016/j.ncrna.2024.06.014.
Implications of lncRNAs in -associated gastrointestinal cancers: underlying mechanisms and future perspectives.
Zhang L, Yu F, Zhang Y, Li P
Front Cell Infect Microbiol. 2024; 14:1392129.
PMID: 39035354
PMC: 11257847.
DOI: 10.3389/fcimb.2024.1392129.
A New linc(-RNA) Between NFAT/MEF2 and Cardiac Hypertrophy.
Gao C, Wang Y
Circ Res. 2024; 135(3):450-452.
PMID: 39024397
PMC: 11423791.
DOI: 10.1161/CIRCRESAHA.124.324794.
YTHDC1 mA-dependent and mA-independent functions converge to preserve the DNA damage response.
Elvira-Blazquez D, Fernandez-Justel J, Arcas A, Statello L, Goni E, Gonzalez J
EMBO J. 2024; 43(16):3494-3522.
PMID: 38951610
PMC: 11329685.
DOI: 10.1038/s44318-024-00153-x.